ZYDUS LIFESCIENCES
Back to Balance Sheet
|
ZYDUS LIFESCIENCES Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹732 Cr | ₹753 Cr | ₹801 Cr | ₹656 Cr | ₹657 Cr |
What is the latest Contingent Liabilities ratio of ZYDUS LIFESCIENCES ?
Year | Contingent Liabilities |
---|---|
Mar2025 | ₹732 Cr |
Mar2024 | ₹753 Cr |
Mar2023 | ₹801 Cr |
Mar2022 | ₹656 Cr |
Mar2021 | ₹657 Cr |
How is Contingent Liabilities of ZYDUS LIFESCIENCES Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹732 Cr | -2.84 | |
Mar2024 | ₹753 Cr | -5.98 | |
Mar2023 | ₹801 Cr | 22.19 | |
Mar2022 | ₹656 Cr | -0.24 | |
Mar2021 | ₹657 Cr | - |
Compare Contingent Liabilities of peers of ZYDUS LIFESCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ZYDUS LIFESCIENCES | ₹97,576.2 Cr | 0.3% | 1.3% | -17.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹405,872.0 Cr | -2.1% | 1.7% | 6.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹177,609.0 Cr | -1.5% | 1.5% | 46.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,277.0 Cr | 2.5% | 11.2% | 15.3% | Stock Analytics | |
CIPLA | ₹119,184.0 Cr | -1% | -1.7% | -1.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,116.0 Cr | -0.1% | -5% | -5.6% | Stock Analytics |
ZYDUS LIFESCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ZYDUS LIFESCIENCES | 0.3% |
1.3% |
-17.7% |
SENSEX | -0.1% |
1% |
1.8% |
You may also like the below Video Courses